Skip to main content
logo
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
117.02
+4.17 (3.70%)
Aug 12, 2026, 2:39 PM EDT - Market open

Rhythm Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8,0577,1943,4932,7321,649502
Market Cap Growth
31.88%105.97%27.85%65.71%228.51%-61.84%
Enterprise Value
7,8366,9403,3192,4571,317209.53
Last Close Price
117.02107.0455.9845.9729.129.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
32.3837.9126.8435.2869.74159.11
PB Ratio
75.4151.73160.7416.096.241.77
P/TBV Ratio
80.4452.01219.5116.295.921.77

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
31.4636.5725.5031.7455.7266.43

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.020.000.000.01
Net Debt / Equity Ratio
-3.18-2.77-14.57-1.62-1.25-1.03
Net Debt / EBITDA Ratio
1.642.021.201.501.871.73
Net Debt / FCF Ratio
3.113.302.782.021.912.00
Asset Turnover
0.520.430.360.220.070.01
Inventory Turnover
0.940.880.981.611.4110.79
Quick Ratio
3.003.922.945.278.536.81
Current Ratio
3.454.413.245.588.907.10
Return on Equity (ROE)
-20.23%-90.45%-155.91%-85.10%-66.05%-30.89%
Return on Assets (ROA)
-43.96%-44.13%-73.34%-51.71%-50.32%-65.84%
Return on Capital Employed (ROCE)
-58.33%-58.99%-95.80%-59.45%-56.99%-74.72%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-8.09%-6.54%-5.76%-10.65%-5.08%-12.40%
Total Shareholder Return
-8.09%-6.54%-5.76%-10.65%-5.08%-12.40%
SEC Filings: 10-K · 10-Q